(0.11%) 5 254.35 points
(0.12%) 39 807 points
(-0.12%) 16 379 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(-0.06%) $0.926
(-0.09%) $10.83
(-0.11%) $0.791
(-0.21%) $92.38
Live Chart Being Loaded With Signals
Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States...
Stats | |
---|---|
Today's Volume | 38 147.00 |
Average Volume | 16 975.00 |
Market Cap | 6.39M |
EPS | $-1.030 ( 2023-11-09 ) |
Next earnings date | ( $-1.040 ) 2024-04-04 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.390 |
ATR14 | $0.0220 (1.26%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-01-26 | Siegert Michelle | Buy | 9 900 | Stock Option (Right to Buy) |
2023-01-26 | Wasilewski Margaret | Buy | 11 400 | Stock Option (Right to Buy) |
2023-01-26 | Raad Teofilo David | Buy | 34 900 | Stock Option (Right to Buy) |
2023-01-26 | Bazemore Todd | Buy | 1 700 | Stock Option (Right to Buy) |
2023-01-26 | Higgins Michael J | Buy | 2 436 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
100.00 |
Last 94 transactions |
Buy: 13 676 591 | Sell: 104 308 |
Pulmatrix Inc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Pulmatrix Inc Financials
Annual | 2023 |
Revenue: | $7.30M |
Gross Profit: | $7.30M (100.00 %) |
EPS: | $-3 866.74 |
Q3 | 2023 |
Revenue: | $1.75M |
Gross Profit: | $1.33M (75.70 %) |
EPS: | $-1.030 |
Q2 | 2023 |
Revenue: | $1.84M |
Gross Profit: | $1.40M (76.14 %) |
EPS: | $-1.040 |
Q1 | 2023 |
Revenue: | $1.50M |
Gross Profit: | $1.10M (73.25 %) |
EPS: | $-1.180 |
Financial Reports:
No articles found.
Pulmatrix Inc
Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled small particles easily respirable and emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing Pulmazole, an inhaled anti-fungal drug for the treatment of allergic bronchopulmonary aspergillosis in patients with asthma, and in patients with cystic fibrosis; PUR1800, a narrow spectrum kinase inhibitor that is in Phase 1b clinical trials for patients with stable moderate-severe chronic obstructive pulmonary disease; and PUR3100, an iSPERSE formulation of dihydroergotamine for the treatment of acute migraine. The company has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates; a development and commercialization agreement with Cipla Technologies LLC for the development and commercialization of Pulmazole; and a collaboration and license agreement with Sensory Cloud, Inc. Pulmatrix, Inc. was founded in 2003 and is headquartered in Lexington, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators